Responsiveness of eyes with polypoidal choroidal vasculopathy with choroidal hyperpermeability to intravitreal ranibizumab

Table 2 Comparison of choroidal/foveal thickness and visual acuity between two groups

	HP group (n = 21)	NP group (n = 21)	P value†
Central choroidal thickness (μm)	378.6 ± 92.5	192.5 ± 58.1	<.001*
Baseline CFT (μm)	424 ± 147	461 ± 174	0.554
Post CFT (μm)	363 ± 131	366 ± 140	0.821
Reduction rate of CFT (%)	14.0 ± 7.5	20.4 ± 8.7	0.013*
Baseline VA	0.281 ± 0.269	0.365 ± 0.377	0.725
Post VA	0.274 ± 0.250	0.368 ± 0.392	0.715

†Mann–Whitney U test. *Significant value. CFT Central foveal thickness, HP Hyperpermeability, NP Normal permeability, VA Visual acuity.

ISSN: 1471-2415